Fielmann Group AGXSWX:FIE 85 PEG Ratio is 0.92 as of Jun. 27, 2026, which is 78% below its 10-year median of 4.27. GuruFocus rates XSWX:FIE with a GF Score™ of 85/100 and a GF Value™ of CHF49.51. The stock has 2 warning signs investors should review. Among 208 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 75.96% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Fielmann Group AG's PEG Ratio or its related term are showing as below:
XSWX:FIE'
s PEG Ratio Range Over the Past 10 Years
Min: 0.93 Med: 4.27 Max: 76.2
Current: 0.93
During the past 13 years, Fielmann Group AG's highest PEG Ratio was 76.20. The lowest was 0.93. And the median was 4.27.
XSWX:FIE's PEG Ratio is ranked better than 75.96% of 208
companies
in the Medical Devices & Instruments industry
Industry Median: 1.915
vs XSWX:FIE: 0.93
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Fielmann Group AG (XSWX:FIE) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Fielmann Group AG PEG Ratio Related Terms
Fielmann Group AG PEG Ratio Historical Data
* Premium members only.
The historical data trend for Fielmann Group AG's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Fielmann Group AG (XSWX:FIE) has a PEG Ratio of 0.92 as of Jun. 27, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Fielmann Group AG and its competitors. This is 78% below median its historical median of 4.27. Over the past decade, Fielmann Group AG's PEG Ratio has ranged from 0.93 to 76.20. According to the industry distribution chart, Fielmann Group AG ranks #50 out of 208 companies in the Medical Devices & Instruments industry, placing it in the top 24%.
Is Fielmann Group AG's PEG Ratio too high?
Fielmann Group AG's current PEG Ratio of 0.92 is 78% below median its 10-year median of 4.27. Over the past 10 years, this metric has ranged from a low of 0.93 to a high of 76.20. The Medical Devices & Instruments industry median PEG Ratio is 1.92. Fielmann Group AG's value of 0.92 is 52% below this industry median. Based on the distribution chart, Fielmann Group AG ranks #50 out of 208 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Fielmann Group AG has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's PEG Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #50 out of 208 companies for PEG Ratio. This places Fielmann Group AG in the top 24% of its industry — outperforming the majority of peers. The industry median PEG Ratio is 1.92. Fielmann Group AG's value of 0.92 is 52% below this benchmark. Historically, Fielmann Group AG's own PEG Ratio has ranged from 0.93 to 76.20 over the past decade. While the company's 10-year median is 4.27 vs. the industry median of 1.92, Fielmann Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 1.92, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current PEG Ratio of 0.92 is 52% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Fielmann Group AG and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 1.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current PEG Ratio is 0.92, which is 78% below median its own 10-year median of 4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current PEG Ratio of 0.92. The stock's GF Value™ is CHF49.51, compared to a current price of CHF40.45 — trading 18.3% below its estimated fair value. The current PEG Ratio is 0.92, which is 78% below median its 10-year median of 4.27 and 52% below the Medical Devices & Instruments industry median of 1.92. Fielmann Group AG's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current PEG Ratio is 0.92 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF40.45 is trading 18.3% below its estimated GF Value™ of CHF49.51.
Key valuation signals for XSWX:FIE:
PEG Ratio: 0.92 (78% below median its 10-year median of 4.27)
GF Value™: CHF49.51 vs. price of CHF40.45 (18.3% below fair value)
Industry Position: 52% below the Medical Devices & Instruments median (#50 of 208)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
85GF Score
Get the complete analysis for XSWX:FIE
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
